BioSig BSGM Stock
BioSig Price Chart
BioSig BSGM Financial and Trading Overview
| BioSig stock price | 1.36 USD |
| Previous Close | 1.23 USD |
| Open | 1.26 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1100 |
| Day's Range | 1.24 - 1.35 USD |
| 52 Week Range | 0.25 - 1.65 USD |
| Volume | 267.28K USD |
| Avg. Volume | 321.34K USD |
| Market Cap | 89.63M USD |
| Beta (5Y Monthly) | 1.398943 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.7 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.5 USD |
BSGM Valuation Measures
| Enterprise Value | 86.01M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.5428572 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 316.72055 |
| Price/Book (mrq) | 41.333336 |
| Enterprise Value/Revenue | 303.933 |
| Enterprise Value/EBITDA | -3.275 |
Trading Information
BioSig Stock Price History
| Beta (5Y Monthly) | 1.398943 |
| 52-Week Change | 82.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.65 USD |
| 52 Week Low | 0.25 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 0.89 USD |
BSGM Share Statistics
| Avg. Volume (3 month) | 321.34K USD |
| Avg. Daily Volume (10-Days) | 332.42K USD |
| Shares Outstanding | 72.28M |
| Float | 58.6M |
| Short Ratio | 6 |
| % Held by Insiders | 18.16% |
| % Held by Institutions | 8.06% |
| Shares Short | 1.82M |
| Short % of Float | 2.97% |
| Short % of Shares Outstanding | 2.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -9394.34% |
| Gross Margin | 79.85% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -187.34% |
| Return on Equity (ttm) | -461.040% |
Income Statement
| Revenue (ttm) | 283K USD |
| Revenue Per Share (ttm) | 0.006 USD |
| Quarterly Revenue Growth (yoy) | -37.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -26264000 USD |
| Net Income Avi to Common (ttm) | -26640000 USD |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.41M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 689K USD |
| Total Debt/Equity (mrq) | 34.19 USD |
| Current Ratio (mrq) | 0.764 |
| Book Value Per Share (mrq) | 0.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21412000 USD |
| Levered Free Cash Flow (ttm) | -9792250 USD |
Profile of BioSig
| Country | United States |
| State | CT |
| City | Westport |
| Address | 55 Greens Farms Road |
| ZIP | 06880 |
| Phone | 203 409 5444 |
| Website | https://www.biosig.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 47 |
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Q&A For BioSig Stock
What is a current BSGM stock price?
BioSig BSGM stock price today per share is 1.36 USD.
How to purchase BioSig stock?
You can buy BSGM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioSig?
The stock symbol or ticker of BioSig is BSGM.
Which industry does the BioSig company belong to?
The BioSig industry is Medical Devices.
How many shares does BioSig have in circulation?
The max supply of BioSig shares is 9.33M.
What is BioSig Price to Earnings Ratio (PE Ratio)?
BioSig PE Ratio is now.
What was BioSig earnings per share over the trailing 12 months (TTM)?
BioSig EPS is -4.7 USD over the trailing 12 months.
Which sector does the BioSig company belong to?
The BioSig sector is Healthcare.
BioSig BSGM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}